Navigation Links
Enerkem appoints new Chief Financial Officer

MONTREAL, Feb. 18 /PRNewswire/ - Enerkem Inc., a leading waste-to-biofuels and advanced chemicals technology company, today announced that Mr. Patrice Ouimet has joined the company as Vice-President and Chief Financial Officer.

Mr. Ouimet brings a wealth of knowledge to Enerkem's current seasoned team of executives, with substantial experience in corporate strategy, corporate development and investment banking. Prior to joining Enerkem, Mr. Ouimet was Vice-President, Corporate Development and Enterprise Risk Management for Gildan Activewear, an international apparel manufacturer and marketer. As a Chartered Accountant, Mr. Ouimet began his career with Ernst & Young. He later worked in the investment banking sector, where he provided strategic and financial advice on mergers and acquisitions as well as capital markets transactions to a diversified client base, primarily in the industrial and paper & forest products sectors. Mr. Ouimet was Director, Mergers and Acquisitions at Lazard and Director, Investment Banking at CIBC World Markets.

"I am thrilled to welcome Patrice Ouimet to Enerkem. He is an experienced finance executive and his knowledge of capital markets transactions and manufacturing brings valuable skill sets to our company," said Vincent Chornet, President and Chief Executive Officer of Enerkem. "Mr. Ouimet's versatile experience will prove to be a great asset for Enerkem, as a growing company that is fast becoming a leader in an even faster developing advanced biofuels industry."

About Enerkem

Enerkem is a leading waste-to-biofuels company. Its proprietary thermo-chemical technology converts residual materials, such as non-recyclable municipal solid waste, into clean transportation fuels, advanced chemicals and electricity. The company was founded in 2000 and currently operates two plants in Canada: a pilot facility in Sherbrooke and a commercial-scale plant in Westbury. It will soon start the construction of a waste-to-biofuels plant in Edmonton, Canada, and is currently developing a similar project in Mississippi, for which it was awarded US$50 million in funding by the U.S. Department of Energy (DOE).

/NOTE TO PHOTO EDITORS: A photo accompanying this release is available at Images are free to accredited members of the media/

SOURCE Enerkem Inc.

SOURCE Enerkem Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Enerkem Awarded $50 Million Funding by U.S. Department of Energy for its Mississippi Biorefinery Project
2. Enerkem Named an Emerging Cleantech Leader in Canada
3. Enerkem Announces Unique Community Energy Project
4. Enerkem Announces Construction Start on Advanced Energy Research Facility in Edmonton, Alberta
5. Enerkem Announces World-Class Advanced Energy Research Center in Edmonton, Alberta, Canada
6. Enerkem GreenField Alberta Biofuels Awarded Permit to Build Worlds First Commercial Municipal Waste-to-Biofuels Facility
7. Enerkem announces plans to enter the United States with next-generation biofuels project in Mississippi
8. Enerkem announces first commercial-scale biofuels and biochemicals plant is entering start-up phase
9. Enerkem Expands Executive Management Team
10. GreenField Ethanol and Enerkem Announce Plans to Make Cellulosic Ethanol a Commercial Reality
11. Enerkem announces progress on construction of Canadas first cellulosic ethanol plant
Post Your Comments:
(Date:6/27/2016)... 2016  Liquid Biotech USA ... a Sponsored Research Agreement with The University of ... from cancer patients.  The funding will be used ... with clinical outcomes in cancer patients undergoing a ... be employed to support the design of a ...
(Date:6/24/2016)... ... June 24, 2016 , ... While the majority of commercial spectrophotometers ... 5000 and the 6000i models are higher end machines that use the more unconventional ... spectrophotometer’s light beam from the bottom of the cuvette holder. , FireflySci has ...
(Date:6/23/2016)... Mass. , June 23, 2016   ... development of novel compounds designed to target cancer ... napabucasin, has been granted Orphan Drug Designation from ... the treatment of gastric cancer, including gastroesophageal junction ... stemness inhibitor designed to inhibit cancer stemness pathways ...
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... ... Plate® YM (Yeast and Mold) microbial test has received AOAC Research Institute approval ... of microbial tests introduced last year,” stated Bob Salter, Vice President of Regulatory ...
Breaking Biology Technology:
(Date:6/7/2016)... June 7, 2016  Syngrafii Inc. and San ... relationship that includes integrating Syngrafii,s patented LongPen™ eSignature ... This collaboration will result in greater convenience for ... union, while maintaining existing document workflow and compliance ... ...
(Date:6/2/2016)... , June 2, 2016   The Weather Company ... announcing Watson Ads, an industry-first capability in which consumers will ... being able to ask questions via voice or text and ... Marketers have long sought an ... consumer, that can be personal, relevant and valuable; and can ...
(Date:5/24/2016)... Calif. , May 24, 2016 Ampronix facilitates superior patient care by ... LMD3251MT  3D medical LCD display is the latest premium product recently added to the ... ... ... Sony 3d Imaging- LCD Medical Display- Ampronix News ...
Breaking Biology News(10 mins):